19
Views
1
CrossRef citations to date
0
Altmetric
Original

Structural aspects and clinical relevance of Aspergillus fumigatus antigens/allergens

, , , , &
Pages 261-267 | Published online: 09 Jul 2009

References

  • Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–805
  • Perea S, Patterson TF. Invasive Aspergillus infections in hematologic malignancy patients. Semin Respir Infect 2002; 17: 99–105
  • Hage CA, Goldman M, Wheat LJ. Mucosal and invasive fungal infections in HIV/AIDS. Eur J Med Res 2002; 7: 236–241
  • Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 11–23
  • Crameri R, Blaser K. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002; 19: 151–157
  • Hayes-Lattin B, Maziarz RT. Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders. Leuk Lymphoma 2004; 45: 669–680
  • Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459–1466
  • Fridkin SK, Jarvis WE. Epidemiology of noscomial fungal infections. Clin Microbiol Rev 1996; 9: 499–511
  • Lin SJ, Schranz J, Teuch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366
  • Casadvall A, Feldmesser M, Pirofski LA. Induced humoral immunity and vaccination against major human fungal pathogens. Curr Opin Microbiol 2002; 5: 386–391
  • de Repentigny L, Petitbois S, Boushira M, et al. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect Immun 1993; 61: 3791–3802
  • Cenci E, Mencacci A, Bacci A, et al. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000; 165: 381–388
  • Horner WE, Helbling A, Salvaggio JE, Lehrer SB. Fungal allergens. Clin Microbiol Rev 1995; 8: 161–179
  • Mari A, Schneider P, Wally V, Breitenbach M, Simon-Nobbe B. Sensitization to fungi: Epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy 2003; 33: 1429–1438
  • Crameri R, Weichel M, Flückiger S, Glaser AG, Rhyner C. Fungal allergies: a yet unsolved problem. Chem Immunol Allergy 2006; 91: 121–133
  • Vailes L, Sridhara S, Cromwell O, et al. Quantitation of major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001; 107: 641–646
  • Kurup VP, Kumar A. immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991; 4: 439–456
  • Shah A, Khan ZU, Chaturverdi S, et al. Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term follow-up. J Asthma 1989; 21: 109–115
  • Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115: 99–114
  • Crameri R, Kodzius R, Konthur Z, et al. Tapping allergen repertoires by advanced cloning technologies. Int Arch Allergy Immunol 2001; 124: 43–47
  • Kodzius R, Rhyner C, Konthur Z, et al. Rapid identification of allergen-encoding cDNA clones by phage display and high density arrays. Combin Chem High Throughput Screen 2003; 6: 147–154
  • Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998; 10: 1211–1216
  • Hemmann S, Nilolaizik WH, Schöni MH, Blaser K, Crameri R. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998; 28: 1155–1160
  • Casaulta C, Flückiger S, Crameri R, Blaser K, Schöni MH. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol 2005; 16: 217–225
  • Hemmann S, Ismail C, Blaser K, Menz G, Crameri R. Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus. Clin Exp Allergy 1998; 28: 860–867
  • Schmid-Grendelmeier P, Crameri R. Recombinant allergens for skin testing. Int Arch Allergy Immunol 2001; 125: 96–111
  • Nikolaizik WH, Weichel M, Blaser K, Crameri R. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med 2002; 165: 916–921
  • Weichel M, Flückiger S, Crameri R. Molecular characterization of mould allergens involved in respiratory complications. Rec Devel Resp Crit Care Med 2002; 2: 29–45
  • Nierman WC, Pain A, Anderson MJ, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 2005; 438: 1151–1156
  • Galgan JE, Calvo SE, Cumo C, et al. Sequencing Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 2005; 438: 1105–1115
  • Flückiger S, Limacher A, Glaser AG, Scapozza L, Crameri R. Structural aspects of cross-reactive allergens. Rec Res Devel Allergy Clin Immunol 2004; 5: 57–75
  • Aalberse RC. Structural features of allergenic molecules. Chem Immunol Allergy 2006; 91: 134–146
  • Crameri R, Faith A, Hemmann S, et al. Humoral and cell mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 1996; 184: 265–270
  • Mayer C, Appenzeller U, Seelbach H, et al. Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J Exp Med 1999; 189: 1507–1512
  • Appenzeller U, Mayer C, Menz G, Blaser K. IgE-mediated reactions to autoantigens in allergic diseases. Int Arch Allergy Immunol 1999; 118: 193–196
  • Flückiger S, Mittl PRE, Scapozza S, et al. Comparison of the drystal structures of the human manganese superoxide dismutase ant the homologous Aspergillus fumigatus allergen at 2- Å resolution. J Immunol 2002; 168: 1267–1272
  • Flückiger S, Scapozza L, Mayer C, et al. Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int Arch Allergy Immunol 2002; 128: 292–303
  • Flückiger S, Fijten H, Whitley P, Blaser K, Crameri R. Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 2002; 32: 10–17
  • Limacher A, Kloer DP, Flückiger S, Folkers G, Crameri R, Scapozza L. The crystal structure of Aspergillus fumigatus cyclophilin reveals 3D domain swapping of a central element. Structure 2006, 14: 185–195.
  • Glaser AG, Limacher A, Flückiger S et al. Analysis of the cross-reactivity and of the 1.5 Å crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem J 2006, 396: 41–49
  • Weichel M, Glaser AG, Ballmer-Weber BK, Schmid-Grendelmeier P, Crameri R. Wheat and maize thioredoxins: a novel cross-reactive cereal allergen family related to baker's asthma. J Allergy Clin Immunol 2006, 117: 676–681.
  • Limacher A, Glaser GA, Meyer C et al. The crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new pan-allergen family. J Immunol 2006 ( submitted).
  • Moser M, Crameri R, Menz G, et al. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type 1 skin test reactivity. J Immunol 1992; 149: 454–460
  • Moser M, Crameri R, Brust E, Suter M, Menz G. Diagnosic value or recombinant Aspergillus fumigatus allergen I/a for skin testing and serology. J Allergy Clin Immunol 1994; 93: 1–11
  • Lamy B, Davies J. Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide. Nucleic Acids Res 1991; 19: 1001–1005
  • Lamy B, Moutaouakil M, Latgé JP, Davies J. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol 1991; 5: 1811–1815
  • Moser M, Crameri R, Menz G, Suter M. Recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) in the diagnosis of Aspergillus related diseases. Agents Actions 1993; 43: 131–127
  • Sacco G, Drickamer K, Wool IG. The primary structure of the cytotoxin a-sarcin. J Biol Chem 1983; 258: 5811–5818
  • Fernandez-Luna JL, Lopez-Otin C, Soriano F, Méndez E. Complete amino acid sequence of the Aspergillus cytotoxin mitogillin. Biochemistry 1985; 24: 861–867
  • Kao R, Martinez-Ruiz A, Martinez del Pozo A, Crameri R, Davies J. Mitogillin and related fungal ribotoxins. Meth Enzymol 2001; 341: 324–335
  • Achatz G, Oberkofler H, Lechnauer E, et al. Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol 1995; 32: 213–227
  • Breiteneder H, Radauer C. A classification of plant food allergens. J Allergy Clin Immunol 2004; 113: 821–830
  • Wagner S, Sowka S, Mayer C, et al. Identification of a Hevea brasiliensis latex manganese superoxide dismutase (Hev b 10) as a cross-reactive allergen. Int Arch Allergy Immunol 2001; 125: 120–127
  • Cadot P, Diaz JF, Proost P, et al. Purification and characterization of an 18-kd allergen of birch (Betula verrucosa) pollen: identification as a cyclophilin. J Allergy Clin Immunol 2000; 105: 286–291
  • Thomas WR, Smith W. Towards defining the full spectrum of important house dust mite allergens. Clin Exp Allergy 1999; 29: 896–904
  • Yang X, Moffat K. Inisghts into specificity of cleavage and mechanism of cell entry from the crystal structure of the highly specific Aspergillus ribotoxin, restrictocin. Structure 1996; 4: 837–852
  • Kumar PR, Eswaramoorthy S, Vithayathil PJ, et al. The tertiary structure at 1.59 Å resolution and the proposed amino acid sequence of a family-11 xylanase from the thermophilic fungus Paecilomyces varoti bainer. J Mol Biol 2000; 295: 581–593
  • Aalberse RC. Structural biology of allergens. J Allergy Clin Immunol 2000; 106: 228–238
  • Kao R, Davies J. Fungal ribotoxins: a family of naturally engineered targeted toxins?. Biochem Cell Biol 1995; 73: 1151–1159
  • Henriksen A, King TP, Mirza O, et al. Major allergen of yellow jackets, ves v 5: structural characterization of a pathogenesis-related protein superfamily. Proteins 2001; 45: 438–448
  • Simon-Nobbe B, Probst G, Kajava AV, et al. IgE-binding epitopes of enolase, a highly conserved fungal allergen. J Allergy Clin Immunol 2000; 106: 887–895
  • American Academy of Allergy. Asthma and Immunology. Position statement. The use of standardized allergen extracts. J Allergy Clin Immunol 1997; 99: 583–586
  • Chapman MD, Smith AM, Vailes LD, et al. Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2002; 106: 409–418
  • Niederberger V, Horak F, Vrtala S, et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci USA 2004; 101(Suppl. 2)14677–14682
  • Jutel M, Jaeger L, Suck R, et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005; 116: 608–613
  • van Hage-Hamsten M, Valenta R. Specific immunotherapy – the induction of new IgE-specificities?. Allergy 2002; 57: 375–377
  • Heiss S, Mahler V, Steiner R, et al. Component-resolved diagnosis (CRD) of type i allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol 1999; 113: 830–837
  • Müller UR. Recent developments and future strategies for immunotherapy of insect venom allergy. Curr Opin Allergy Clin Immunol 2003; 3: 299–303
  • Schmid-Grendelmeier P, Flückiger S, Disch R, et al. IgE-mediated ant T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005; 115: 1068–1075
  • Schweibacher M, Israel L, Heesemann J, Ebel F. Asp f 6, an Aspergillus allergen specifically recognized by IgE from patients with allergic bronchopulmonary aspergillosis, is differentially expressed during germination. Allergy 2005; 60: 1430–1435
  • Kauffman JF, Tomee JFC. Defense mechanisms of the airways against Aspergillus fumigatus: role in invasive aspergillosis. Chem Immunol 2002; 81: 94–113
  • Larsen TM, Wedekind JE, Rayment I, Reed GH. A carboxylate oxygen of the substrate bridges the magnesium ions at the active esite of enolase: structure of the yeast enzyme complexed with the equilibrium mixture of 2-phosphoglycerate and phosphoenolpyruate at 1.8 Å resolution. Biochemistry 1996; 35: 4349–4358
  • Weichel M, Schmid-Grendelmeier P, Flückiger S, et al. Nuclear transport factor 2 represents a novel cross-reactive fungal allergen. Allergy 2003; 58: 198–206

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.